Skip to main content
. 2021 Jan 25;22(3):1162. doi: 10.3390/ijms22031162

Figure 3.

Figure 3

Figure 3

Docking poses of selected compound 4k onto the active site of glycogen synthase kinase-3 beta (GSK-3β) (PDB ID: 1UV5). (A) Two-dimensional (2D) interaction data and residues of bound ligand 6-bromoindirubin-3′-oxime within the ATP pocket of the target. (B) 2D of the compound within the ATP pocket with the corresponding hydrogen bonding and aromatic interactions with residues. (C) Three-dimensional (3D) analysis of the target compound 4k mapped to the reference drug, i.e., 6-Bromoindirubin-3′-oxime.